- AbbVie has expanded its global partnership with BioLabs by becoming the founding sponsor of BioLabs University of Toronto
- The new ~40,000 sq. ft. facility at MaRS Discovery District will support up to 30 early-stage biotech startups with lab space, shared infrastructure, and industry mentorship
- Through the AbbVie Biotech Innovators Awards, selected startups will receive one year of free lab/office space and guidance from AbbVie’s scientific and business leaders
- The collaboration aims to accelerate life sciences R&D, strengthen Canada’s biotech ecosystem, and support translation of early research into clinical innovation
Takeaways:
AbbVie is doubling down on Canada as a discovery hub by becoming the founding sponsor of BioLabs University of Toronto, a ~40,000 sq. ft shared lab at MaRS that can house about 30 early‑stage biotechs at a time with plug‑and‑play wet‑lab, office space, and programming.
Through the AbbVie Biotech Innovators Awards, select startups will get a year of free lab and office space plus mentorship from AbbVie’s scientific and business leaders, positioning this as more than branding, it’s a structured pipeline‑building move that embeds AbbVie early in Canada’s innovation flow and strengthens the local ecosystem’s capacity to translate academic research into clinical‑stage assets.
Source: AbbVie
